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Abstract
Extended-Spectrum Beta-Lactamases (ESBL) and AmpC Beta-Lactamases (AmpC) are of great concern because 
of their ability to cause antimicrobial resistance in Enterobacteriaceae hampering the effect of treatment with 
beta-lactam antibiotics. The main objective of this study was to assess the relative importance of different types of 
meat for the exposure of consumers to ESBL/AmpC and their potential relevance for human cases in Denmark.
This was assessed by weighting the prevalence of each genotype of ESBL/AmpC-producing E. coli (ESBL/AmpC-
PEC) in imported and nationally produced broiler meat, pork and beef with the meat consumption patterns in 
Denmark. Data originated from the Danish surveillance programme for antibiotic use and antibiotic resistance 
(DANMAP) for 2009 to 2011. Data about human ESBL cases in 2011 were also collected to assess a possible 
genotype overlap. Uncertainty was assessed by inspecting beta distributions of the genotypes in each type of meat.
Broiler meat represented the largest part of the estimated ESBL/AmpC contaminated pool of meat (83.8%) 
compared to pork (12.5%) and beef (3.7%). CMY-2 was the genotype with the highest relative importance for 
human exposure (58.3%). However, it is rarely found in humans in Denmark.
In general the overlap between ESBL/AmpC genotypes in meat and those found in human E. coli infections 
isolates was limited. CTX-M-1 had a relative importance of 28.8% for human exposure through meat. The 
prevalence of CTX-M-1 in humans was 7.3% of E. coli urinary tract infections and 8.0% of E. coli bloodstream 
infections. Hence, the genotype CTX-M-1 was considered the most relevant genotype found in meat when 
referring to human exposure. This suggests that meat might constitute a less important source of ESBL/AmpC 
exposure of humans in Denmark than previously thought. Nonetheless, more detailed surveillance data are 
required to determine the contribution of meat compared to other sources, such as pets and hospitals.
Introduction
Extended-Spectrum Beta-Lactamases (ESBL) were defined by the EFSA Panel on Biological Hazards (BIOHAZ) 
as plasmid-encoded enzymes found in the bacterial family Enterobacteriaceae. ESBL confer resistance to a 
variety of beta-lactam antibiotics, including penicillins, 2nd, 3rd and 4th generation cephalosporins and mono-
bactams (EFSA, 2011). The BIOHAZ panel also stated that AmpC Beta-Lactamases (AmpC) are intrinsic cepha-
losporinases found on the chromosomal DNA of many Gram-negative bacteria. However, the number of AmpC 
enzymes that are plasmid-borne, such as CMY-2, is increasing (EFSA, 2011).
Economically and socially, the burden of antimicrobial resistance is quite significant (De Kraker et al., 2011). 
The World Health Organization (WHO) calculated 25,000 deaths each year in the European Union (EU) due to 
infections with antibiotic resistant bacteria (WHO, 2011a). The increase of ESBL/AmpC is particularly worrying 
due to their resistance to 3rd and 4th generation cephalosporins, which have been considered critically import-
ant to human medicine (WHO, 2011b). Recently, a possible link has been made to food and food-producing 
animals (EFSA, 2011; SAGAM, 2009), stressing the importance of scrutinizing the role of food animal products 
to human ESBL/AmpC-producing bacteria (ESBL/AmpC-PB) infections.
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Denmark, as the other Nordic countries, has always been considered having a low animal prevalence of anti-
microbial resistance, due to the conscious use and restrictive measures related to antibiotics. The “Yellow card” 
initiative (Alban et al., 2013) and the cephalosporins ban for use in pigs (Agersø & Aarestrup, 2013) are examples 
of the precautionary Danish policy related to antimicrobial use in animal production.
In 2009, the first Danish surveillance study in meat and live animals with enriched culture method was per-
formed, nowadays described as the preferred method for ESBL/AmpC producers isolation (EFSA, 2011), fol-
lowed by genetic background investigation (Agersø et al., 2012). Since then, this protocol has been repeated 
yearly, revealing an increasing prevalence in Danish broiler meat from 3% in 2009 (data not published) to 44% 
in 2011 (DANMAP, 2011). In the same period, imported broiler meat had prevalences between 36% and 50% 
(DANMAP, 2009, 2010, 2011).
The aim of this project was to determine the relative importance of the various ESBL/AmpC-producing E. coli 
(ESBL/AmpC-PEC) genotypes in different meat types with respect to exposure of Danish meat consumers. 
Moreover, the genotype overlap between isolates found in meat and human cases was evaluated to assess the 
relative importance of meat as a source of ESBL/AmpC-PEC infections in humans.
Material and Methods
Data about the fresh and frozen meat available for consumption in 2009, 2010 and 2011 were collected and 
divided into six categories: imported and domestically produced broiler meat, pork and beef (DTU, 2011). 
Furthermore, the prevalence of the different genotypes found in each category of meat was obtained (DANMAP, 
2009, 2010, 2011). In the DANMAP programme, detection of ESBL/AmpC-PEC is conducted using a selective 
culture method with antimicrobials. This method has a very high sensitivity and is qualitative, hence resulting in 
positive or negative outcome.
To calculate the relative importance of each type of meat and of each genotype for human exposure, the prev-
alence of ESBL/AmpC genotypes was weighted by the amount of meat available for consumption: Weighted 
prevalence (WP) = Prevalence*Meat available for consumption. All the WPs were added to have an ESBL/AmpC 
Total Pool. Finally, the WP of each genotype was divided by the ESBL/AmpC Total Pool: Relative importance 
(RI) = WP/ (ESBL/AmpC Total Pool).
Due to the low frequency of positive samples for pork and beef and the low frequency of testing in general, a 
pool of the 3 years’ sampling was used. However, the described procedure was also applied to each year separate-
ly. The genotype group “Others” included TEM-52 and unknown (i.e. where it was impossible to determine a 
specific genotype) in beef; unknown genotypes in pork; and TEM-20, TEM-52, up-regulated AmpC and un-
known genotypes in broiler meat.
Using the software @Risk 4.5 Palisade Corporation®, beta distributions were created to assess the 95% credibility 
interval (CI) for each the genotype and hereby estimate how high the true prevalence could be given the avail-
able data. The beta distributions were made through a simulation using 1,000,000 iterations. The distributions 
were defined by (s+1, n-s+1), where s represents the number of positive samples for each genotype in each type 
of meat from 2009 to 2011, and n represents the total number of samples tested for ESBL/AmpC-PEC in each 
type of meat within the same 3-year period.
Results
During the period 2009 to 2011, broiler meat contributed the most to the total human exposure to ESBL/AmpC-
PEC representing 83.8% of the total exposure. Danish broiler meat contributed with 37.0% and imported broiler 
meat with 46.8%. Danish and imported pork constituted 6.2% and 6.3% of the ESBL/AmpC positive meat avail-
able for consumption, respectively. Beef had minor relevance representing 1.2% in beef of Danish origin and 
2.5% of imported origin.
The relevance of each genotype varied between the 3 years (Figure 1). Most important was the increase in the 
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role CMY-2 in Danish broiler meat from 4.6% in 2009 to 11.8% in 2010, increasing to 53.5% of the total expo-
sure in 2011. Moreover, CMY-2 constituted the genotype that meat consumers were most exposed to (58.3% 
across the 3-year period). CTX-M-1 was the most frequently isolated genotype in pork and beef at 8.2% and 
2.5% of the total exposure, respectively. Including broiler meat, CTX-M-1 represented 28.8% of the total ESBL/
AmpC positive meat in the Danish market from 2009 to 2011. Overall, Danish meat presented a lower relative 
importance and imported meat contributed to 55.7% of the human exposure.
Figure 1 – Rela-
tive importance 







2009 to 2011. The 
beef genotypes 
are represented 
in blue colours, 
while pork is in 
pink, red and orange, and broiler meat is in green, brown and yellow colours.
CTX-M-15 was the genotype most commonly found in human cases. It was found on rare occasions in Danish 
pigs and cattle at slaughter. However, it has not been detected in meat samples so far. This ESBL genotype was 
estimated to be present in Danish pork and beef below prevalences of 0.7% and 1.0%, respectively, given the 
available data. The prevalence of CTX-M-1 was 2.0% in imported pork (DANMAP, 2009, 2010, 2011), but this 
estimate is uncertain due to the low number of samples. The estimated upper limit of prevalence for this geno-
type was 3.8% in imported pork.
Discussion
A definitive cause-effect association cannot be established through our approach. The limited genotype overlap 
between the meat and human reservoirs indicates that meat might play a minor role for human cases of ESBL/
AmpC-PEC.
Considering that cephalosporins have not been used in poultry in Denmark for more than 10 years it is pos-
sible that the high prevalences detected in Danish broiler meat might be caused by practices upstream in the 
production pyramid. This hypothesis has also arisen in Sweden (Börjesson et al., 2013; SVARM, 2010). Danish 
and Swedish broiler parents come from the same Swedish breeding stock, which in turn is supplied by a Scot-
tish grand-parent breeding company where cephalosporins were used as a prophylactic measure until recently. 
Cross-contamination through the environment, humans or animals, as well as off-label use of cephalosporins, 
should also be considered and investigated. Moreover, it should be studied whether the animal feed is an import-
ant source of ESBL/AmpC-PEC. However, the fact that CMY-2 and CTX-M-1 were also the genotypes detected 
in Swedish broiler meat (SVARM, 2010) and both of them being the only ESBL/AmpC genes persistently de-
tected in Danish broiler meat from 2009 to 2011, supports the hypothesis of a common source upstream in the 
production pyramid. Co-resistance patterns may have facilitated the spread and maintenance of ESBL/AmpC-
PEC (Börjesson et al., 2013).
The discontinuation of the use of cephalosporins in pigs is the most likely explanation for the reduction on the 
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ESBL/AmpC-PEC prevalence seen in these animals in 2011 (Agersø & Aarestrup, 2013). Other factors could also 
have contributed to this diminution, i.e. the “Yellow card” initiative, adopted almost at the same time and that 
initially led to a 25% decrease in use of antimicrobials in livestock (Aarestrup, 2012; Alban et al., 2013).
In humans, the so-called “pandemic CTX-M-15” genotype dominated both in blood and urine ESBL-PEC iso-
lates, with 68.0% and 59.3%, respectively (DANMAP, 2011). CTX-M-1 was detected in 7.3% of urine and 8.0% of 
blood isolates (DANMAP, 2011). However, it should be noted that, particularly for human ESBL-PEC septicae-
mia, the number of cases on which these results are based is quite small (n=25). Consequently, it is possible that 
the true ESBL genotype distribution is slightly diverse from what was found and some genotypes causing infec-
tions may have not been detected. As CTX-M-1, CTX-M-14 was detected both in human infections and meat.
ESBL/AmpC genes found in humans and meat overlapped to a limited extent. It should be highlighted, however, 
that although some genotypes were not found in meat they were found in live animals, indicating their possible 
presence in meat. This is the case of CTX-M-15, which was detected in very low prevalences in Danish pigs and 
in Danish cattle.
This was one of the main motives to assess the uncertainty. This investigation is especially interesting to apply 
to genotypes that were found in live animals and not in meat. The upper 95% CI expected prevalence for ESBL/
AmpC genes not detected in meat (that is the case of CTX-M-15), considering the DANMAP sampling within 
the 3-year period, was 0.7% for Danish pork, 0.9% for imported pork, 1.0% for Danish beef, 1.4% for imported 
beef, 0.9% for Danish broiler meat and 0.7% for imported broiler meat. Such low prevalences points against a 
role of meat for the CTX-M-15 PEC infections in humans. Nonetheless, very little is known about the duration 
of carriage, dominance in the human gut microflora and different ESBL/AmpC-PEC’s ability to survive in the 
human gut environments.
It is of great relevance to highlight that CMY-2 was detected in human infections, but it was not possible to 
calculate its prevalence in humans. Nevertheless, the positive number of samples was low (data not published). 
Considering the possible emergence of CMY-2 E. coli and its relevance for human exposure through meat, it is 
important that its prevalence is calculated in the upcoming years.
Meat might not have such a high impact for human ESBL/AmpC-PEC infections as firstly thought. However, 
this does not exclude the importance of animal production, and even meat, for ESBL/AmpC dissemination, so a 
precautionary approach should probably be taken.
In Denmark, there are limited additional options to control ESBL/AmpC occurrence through the reduction in 
use of cephalosporins in livestock. It is known that other antimicrobials can co-select ESBL/AmpC genes. There-
fore, measures to promote the reduction of antimicrobial use in general, such as the “Yellow card” scheme, may 
have some influence. However, downstream the production chain, other options can be explored. In first place, 
some studies have documented the existence of some risk factors for ESBL/AmpC growing in animals’ gut (Per-
soons et al., 2010). The impact of probiotics in the control of this type of bacteria should also be studied. Sec-
ondly, cross contamination during slaughter should be inspected and, if relevant, hygiene should be improved. 
Other option to consider is to implement decontamination after slaughter. Nonetheless, the role of other sources 
should be assessed, including other foodborne sources, pets and hospitals, so further studies are needed. ESBL/
AmpC-PB is a very complex subject and their emergence, ecology and dynamics is nowadays poorly understood. 
Furthermore, very little is known about the impact of control strategies, which hampers prioritisation of mea-
sures to prevent the emergence and dissemination of ESBL/AmpC-PB. This is a critical point that must urgently 
be further investigated. Finally, we suggest that data collection, in human, food and animal reservoirs, become 
harmonized across the EU. This would not only allow comparison of data between countries, but also facilitate 
studying risk factors and suggest optimal control strategies.
Conclusion
The genotype overlap between the two reservoirs – humans and meat from poultry, pigs and cattle – is low, 
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suggesting that meat might not have such a relevant role for ESBL/AmpC-PEC human infections in Denmark in 
2009-2011 as previously thought. Poultry meat was most relevant for human ESBL/AmpC-PEC exposure fol-
lowed by pork and beef, and Danish meat had a lower relative importance than imported meat. CTX-M-1 and 
CTX-M-14 producing E. coli were found in both humans and animals, but the occurrence of these two geno-
types in humans was not very frequent. “Pandemic” CTX-M-15 was not found in meat samples, but it should not 
be ruled out that it can occur in meat, because it has previously been detected in live animals although at a low 
prevalence. Future studies aiming to obtain a better understanding of the issue of ESBL/AmpC-PEC is required, 
unveiling the factors that lead to ESBL/AmpC emergence and explaining the interface between several sources 
and humans to clarify the increasing occurrence of human cases.
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